An interventional study of audiovisual educational intervention in Visual Loss, sponsored by Brigham and Women's Hospital. Enrolling by invitation at 2 sites in United States. Open to participants aged 18 Years to 89 Years. Per ClinicalTrials.gov, last updated 2026-10-08.
Sponsored by Brigham and Women's Hospital · Not applicable, Interventional, and Other
The goal of this interventional study is to learn if an educational intervention improves awareness in people experiencing visual loss. The main question it aim to answer is:
Participants will be asked to answer questions, engage with an audiovisual educational intervention, and then answer additional questions.
360 studies on the registry are indexed under Vision Disorders; 84 are open to participants now.
This study's planned enrollment of 300 is above the median of 78 across 244 interventional studies indexed under Vision Disorders.
Browse Vision Disorders studies →Brigham and Women's Hospital is the lead sponsor of 1,267 studies on the registry; 228 are open to participants now.
Of its 116 completed or terminated interventional studies of FDA-regulated products, 65 (56%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Other: audiovisual educational intervention
A brief audiovisual educational intervention.
Change from Baseline in Educational Awareness of Shared Themes as Measured by Likert-scale Questions
Higher values (or increases relative to baseline) correspond to better outcomes, with each question having a minimum value of 1 and a maximum value of 5.
Time frame: From baseline to completion of post-intervention questions (e.g., within 1 week).
Change from Baseline in Screening Measures of Depression and Anxiety as Measured by the Patient Health Questionnaire 4 (PHQ-4)
Lower values (or decreases relative to baseline) correspond to better outcomes, with each question having a minimum value of 0 and a maximum value of 3.
Time frame: From baseline to completion of post-intervention questions (e.g., within 1 week).
Change from Baseline of Vision-Related Wellbeing as Measured by the Visual Function Questionnaire 25 (VFQ-25) Socioemotional Wellbeing Subscale
Time frame: From baseline to completion of post-intervention questions (e.g., within 1 week).
Plan to share: No
No publications or documents are linked to this record.
Started Jul 2026 (actual). Primary completion is estimated for May 2027, 10 months after the start.
Of 84 non-industry interventional studies with no phase under Vision Disorders, half reached primary completion within 31 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 51. This study's planned 10 months is below that.
Counting every sponsor, half of 94 studies reached it within 24 months; a quarter within 6 and three quarters within 51.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Brigham and Women's Hospital →